Welcome to CDC stacks | CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : North Carolina - 51128 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : North Carolina
Filetype[PDF-556.04 KB]


Details:
  • Description:
    $2,960,231 Funding for AR Activities Fiscal Year 2017

    1 local CDC fellow

    Funding to local health departments:

    $635,354 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, North Carolina supported responses to 11 HAI/AR outbreaks in healthcare settings and provided outbreak response training to more than 80 local public health and healthcare partners.

    $41,119 - AI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. North Carolina received funding for this activity for the first time in 2017 to better prevent infections and protect patients.

    $251,059 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. North Carolina implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, North Carolina will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.

    $1,163,454 - GONORRHEA RAPID DETECTION & RESPONSE works with state and local epidemiology and laboratory partners to test for and quickly respond to resistant gonorrhea to stop its spread in high risk communities. Only one treatment option remains for gonorrhea and resistance continues to grow. With 2016 funding, North Carolina increased their local response capacity and initiating rapid antibiotic susceptibility testing—which determines how well a gonorrhea strain will respond to specific antibiotics. North Carolina conducted rapid antibiotic susceptibility testing on 21 gonorrhea specimens in July. Test results are used to inform local outbreak response action, national treatment guidelines and antibiotic resistance trends.

    Publication date from document properties.

    North-Carolina-2017-CDC-AR-Investments.pdf

  • Place as Subject:
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
You May Also Like: